Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | 59,744 | reported | 19 Jan 2022 | tx 3+223,844 |
| Astria Therapeutics, Inc. | 0 | reported | 23 Jan 2026 | tx 15+647,500−382,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 262,500 | — | deriv |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 80,000 | — | deriv |
| 21 Mar 2025 | GRANT_AWARD | Astria Therapeutics, Inc. | 262,500 | 0.00 USD | deriv |
| 01 Apr 2024 | EXERCISE | Astria Therapeutics, Inc. | 10,000 | 3.87 USD | |
| 01 Apr 2024 | SALE | Astria Therapeutics, Inc. | 10,000 | 13.59 USD | |
| 01 Apr 2024 | EXERCISE | Astria Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 08 Feb 2024 | GRANT_AWARD | Astria Therapeutics, Inc. | 175,000 | 0.00 USD | deriv |
| 29 Jan 2024 | SALE | Astria Therapeutics, Inc. | 9,200 | 11.15 USD | |
| 29 Jan 2024 | EXERCISE | Astria Therapeutics, Inc. | 9,200 | 3.87 USD | |
| 26 Jan 2024 | EXERCISE | Astria Therapeutics, Inc. | 800 | 3.87 USD | |
| 26 Jan 2024 | SALE | Astria Therapeutics, Inc. | 800 | 11.02 USD | |
| 26 Jan 2024 | EXERCISE | Astria Therapeutics, Inc. | 800 | 0.00 USD | deriv |
| 29 Jan 2024 | EXERCISE | Astria Therapeutics, Inc. | 9,200 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Astria Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 01 Aug 2022 | GRANT_AWARD | Astria Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 19 Jan 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 59,744 | 0.00 USD | deriv |
| 28 Jun 2021 | PURCHASE | Fulcrum Therapeutics, Inc. | 1,100 | 9.16 USD | |
| 10 May 2021 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 163,000 | 0.00 USD | deriv |